Download PDF
TumorDiagnostik & Therapie 2021; 42(03): 209-220
DOI: 10.1055/a-1361-7423
Thieme Onkologie aktuell

Infektionen bei hämatologisch-onkologischen Patienten auf der Intensivstation

Matthias Kochanek
  Klinik I für Innere Medizin der Uniklinik Köln
,
Boris Böll
  Klinik I für Innere Medizin der Uniklinik Köln
,
Alexander Shimabukuro-Vornhagen
  Klinik I für Innere Medizin der Uniklinik Köln
,
Dennis Eichenauer
  Klinik I für Innere Medizin der Uniklinik Köln
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Krebspatienten haben ein hohes Risiko, eine Infektion zu entwickeln, die eine Behandlung auf einer Intensivstation notwendig macht. Dies ist insbesondere bei hämatologischen Erkrankungen der Fall, da das Immunsystem fast immer am Krankheitsgeschehen beteiligt ist. Das Bild der Infektion kann mitunter sehr bunt sein, ist abhängig sowohl von der Primärerkrankung als auch der Krebstherapie und kann bis hin zum Vollbild einer Sepsis reichen.



Publication History

Article published online:
07 April 2021

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Kochanek M, Shimabukuro-Vornhagen A, Russ K. et al Prävalenz von Krebspatienten auf deutschen Intensivstationen. Med Klin Intensivmed Notfmed 2020; 115: 312-319 . doi:10.1007/s00063-019-0594-3
    CrossrefPubMedGoogle Scholar
  • 2 Atkins S, He F. Chemotherapy and beyond. Infect Dis Clin North Am 2019; 33: 289-309 . doi:10.1016/j.idc.2019.01.001
    CrossrefPubMedGoogle Scholar
  • 3 Kochanek M, Schalk E, von Bergwelt-Baildon M. et al Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2019; 98: 1051-1069 . doi:10.1007/s00277-019-03622-0
    CrossrefPubMedGoogle Scholar
  • 4 Probst L, Schalk E, Liebregts T. et al Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study. J Intensive Care 2019; 7: 41 . doi:10.1186/s40560-019-0396-y
    CrossrefPubMedGoogle Scholar
  • 5 Rhodes A, Evans LE, Alhazzani W. et al Surviving Sepsis Campaign: International Guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45: 486-552 . doi:10.1097/CCM.0000000000002255
    CrossrefPubMedGoogle Scholar
  • 6 Singer M, Deutschman CS, Seymour CW. et al The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-810 . doi:10.1001/jama. 2016.0287
    CrossrefPubMedGoogle Scholar
  • 7 Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 Update. Crit Care Med 2018; 46: 997-1000 . doi:10.1097/CCM.0000000000003119
    CrossrefPubMedGoogle Scholar
  • 8 Maschmeyer G, Carratala J, Buchheidt D. et al Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2015; 26: 21-33 . doi:10.1093/annonc/mdu192
    CrossrefPubMedGoogle Scholar
  • 9 Gudiol C, Royo-Cebrecos C, Laporte J. et al Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients. Respirology 2016; 21: 1411-1418 . doi:10.1111/resp.12848
    CrossrefPubMedGoogle Scholar
  • 10 Sandherr M, Hentrich M, von Lilienfeld-Toal M. et al Antiviral prophylaxis in patients with solid tumours and haematological malignancies-update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 2015; 94: 1441-1450 . doi:10.1007/s00277-015-2447-3
    CrossrefPubMedGoogle Scholar
  • 11 von Lilienfeld-Toal M, Berger A, Christopeit M. et al Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer 2016; 67: 200-212 . doi:10.1016/j.ejca.2016.08.015
    CrossrefPubMedGoogle Scholar
  • 12 Poortmans PM, Guarneri V, Cardoso MJ. Cancer and COVID-19: what do we really know?. Lancet 2020; 395: 1884-1885 . doi:10.1016/s0140-6736(20)31240-x
    CrossrefPubMedGoogle Scholar
  • 13 He W, Chen L, Chen L. et al COVID-19 in persons with haematological cancers. Leukemia 2020; 34: 1637-1645 . doi:10.1038/s41375-020-0836-7
    CrossrefPubMedGoogle Scholar
  • 14 Mei H, Dong X, Wang Y. et al Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan. Lancet Oncol 2020; 21: 634-636 . doi:10.1016/s1470-2045(20)30238-2
    CrossrefPubMedGoogle Scholar
  • 15 Kuderer NM, Choueiri TK, Shah DP. et al Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020; 395: 1907-1918 . doi:10.1016/S0140-6736(20) 31187-9
    CrossrefPubMedGoogle Scholar
  • 16 Lee LYW, Cazier JB, Starkey T. et al COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020; 395: 1919-1926 . doi:10.1016/s0140-6736(20)31173-9
    CrossrefPubMedGoogle Scholar
  • 17 Valentine JC, Morrissey CO, Tacey MA. et al A populationbased analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005–2016. BMC Infect Dis 2019; 19: 274 . doi:10.1186/s12879-019-3901-y
    CrossrefPubMedGoogle Scholar
  • 18 Taccone FS, Van den Abeele AM, Bulpa P. et al Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 2015; 19: 7 . doi:10.1186/s13054-014-0722-7
    CrossrefPubMedGoogle Scholar
  • 19 Azoulay E, Pickkers P, Soares M. et al Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 2017; 43: 1808-1819 . doi:10.1007/s00134-017-4947-1
    CrossrefPubMedGoogle Scholar
  • 20 Gerritsen MG, Willemink MJ, Pompe E. et al Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography. PloS One 2017; 12: e0172256 . doi:10.1371/journal.pone.0172256
    CrossrefPubMedGoogle Scholar
  • 21 Wohlfarth P, Turki AT, Steinmann J. et al Microbiologic diagnostic workup of acute respiratory failure with pulmonary infiltrates after allogeneic hematopoietic stem cell transplantation: findings in the era of molecular- and biomarker-based assays. Biol Blood Marrow Transplant 2018; 24: 1707-1714 . doi:10.1016/j.bbmt.2018.03.007
    CrossrefPubMedGoogle Scholar
  • 22 Boch T, Spiess B, Cornely OA. et al Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clin Microbiol Infect 2016; 22: 862-868 . doi:10.1016/j.cmi.2016.06.021
    CrossrefPubMedGoogle Scholar
  • 23 Ruhnke M, Behre G, Buchheidt D. et al Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO). Mycoses 2018; 61: 796-813 . doi:10.1111/myc.12838
    CrossrefPubMedGoogle Scholar
  • 24 Ullmann AJ, Aguado JM, Arikan-Akdagli S. et al Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 (Suppl. 01) e1-e38 . doi:10.1016/j.cmi.2018.01.002
    CrossrefPubMedGoogle Scholar
  • 25 Schmidt-Hieber M, Bierwirth J, Buchheidt D. et al Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2018; 97: 31-49 . doi:10.1007/s00277-017-3183-7
    CrossrefPubMedGoogle Scholar
  • 26 Wilcox MH, Gerding DN, Poxton IR. et al Bezlotoxumab for prevention of recurrent clostridium difficile infection. N Engl J Med 2017; 376: 305-317 . doi:10.1056/NEJMoa1602615
    CrossrefPubMedGoogle Scholar
  • 27 Manthey CF, Dranova D, Christner M. et al Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI). Crit Care 2019; 23: 399 . doi:10.1186/s13054-019-2648-6
    CrossrefPubMedGoogle Scholar
  • 28 Cattaneo C, Di Blasi R, Skert C. et al Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol 2018; 97: 1717-1726 . doi:10.1007/s00277-018-3341-6
    CrossrefPubMedGoogle Scholar
  • 29 La Rosée P, Horne A, Hines M. et al Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019; 133: 2465-2477 . doi:10.1182/blood.2018894618
    CrossrefPubMedGoogle Scholar
  • 30 Henter JI, Horne A, Aricó M. et al HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131 . doi:10.1002/pbc.21039
    CrossrefPubMedGoogle Scholar